Bone tissue engineering (BTE) is a rapidly developing strategy for repairing critical-sized
bone defects to address the unmet need for bone augmentation and skeletal repair. Effective …

The discovery of anti‐retroviral (ARV) drugs over the past 36 years has introduced various
classes, including nucleoside/nucleotide reverse transcriptase inhibitors, non‐nucleoside …

Controlling the backbone architecture of poly (lactic-co-glycolic acid) s (PLGAs) is
demonstrated to have a strong influence on the production and release of acidic …

Purpose A palmitoylated prodrug of emtricitabine (FTC) was synthesized to extend the
drug's half-life, antiretroviral activities and biodistribution. Methods A modified FTC prodrug …

At present, AIDS drugs are typical inhibitors that cannot achieve permanent effects.
Therefore, the research of blocking HIV infection is essential. Especially for people in the …

The development of platforms for the controlled release of therapeutic molecules remains a
crucial research focus, as controlled release reduces the frequency of administration …

HIV infection has been a severe global health burden, with millions living with the virus and
continuing new infections each year. Antiretroviral therapy can effectively suppress HIV …

Abstract Enfuvirtide (T‐20) is a synthetic peptide fusion inhibitor for the human
immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS) …

Antimicrobial peptides, also called body defense peptides, are chemical structures widely
distributed across the animal and vegetal kingdoms that have a fundamental role as part of …

Poly (lactic-co-glycolic acid)(PLGA)-based biodegradable materials have attracted
considerable interest in the field of bioengineering due to their biocompatibility, FDA …